Xtant Medical Holdings (XTNT) EBIT Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Xtant Medical Holdings | 64.46 Mn | 47.14 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 113.22% |
| Sep 30, 2025 | 27.30% |
| Jun 30, 2025 | 69.40% |
| Mar 31, 2025 | 22.69% |
| Dec 31, 2024 | 87.72% |
| Sep 30, 2024 | -39.89% |
| Jun 30, 2024 | -39.23% |
| Mar 31, 2024 | -39.03% |
| Dec 31, 2023 | 16.47% |
| Sep 30, 2023 | -18.72% |
| Jun 30, 2023 | 9.26% |
| Mar 31, 2023 | 1.00% |
| Dec 31, 2022 | 16.38% |
| Sep 30, 2022 | 16.51% |
| Jun 30, 2022 | 27.19% |
| Mar 31, 2022 | 6.53% |
| Dec 31, 2021 | -10.56% |
| Sep 30, 2021 | 5.36% |
| Jun 30, 2021 | 25.38% |
| Mar 31, 2021 | 70.82% |
| Dec 31, 2020 | 36.47% |
| Sep 30, 2020 | 16.60% |
| Jun 30, 2020 | 22.49% |
| Mar 31, 2020 | 4.69% |
| Dec 31, 2019 | 33.74% |
| Sep 30, 2019 | 10.83% |
| Jun 30, 2019 | 15.82% |
| Mar 31, 2019 | 10.94% |
| Dec 31, 2018 | -21.33% |
| Sep 30, 2018 | 9.37% |
| Jun 30, 2018 | -3.90% |
| Mar 31, 2018 | -6.08% |
| Dec 31, 2017 | -46.96% |
| Sep 30, 2017 | -88.86% |
| Jun 30, 2017 | -78.82% |
| Mar 31, 2017 | -15.06% |
| Dec 31, 2016 | 15.40% |
| Sep 30, 2016 | -3.99% |
| Jun 30, 2016 | -49.95% |
| Mar 31, 2016 | -4.06% |
| Dec 31, 2015 | -0.29% |
| Sep 30, 2015 | -18.56% |
| Jun 30, 2015 | -1.61% |